Home/Filings/4/0001562180-23-006236
4//SEC Filing

Birkett Bernard 4

Accession 0001562180-23-006236

CIK 0000105770other

Filed

Aug 7, 8:00 PM ET

Accepted

Aug 8, 3:49 PM ET

Size

17.9 KB

Accession

0001562180-23-006236

Insider Transaction Report

Form 4
Period: 2023-08-02
Birkett Bernard
Sr VP, Chief Financial Officer
Transactions
  • Sale

    Common Stock

    2023-08-02$371.02/sh200$74,2054,366 total
  • Sale

    Common Stock

    2023-08-02$370.38/sh22,134$8,198,0114,566 total
  • Exercise/Conversion

    Common Stock

    2023-08-02$102.51/sh+8,450$866,21012,816 total
  • Exercise/Conversion

    Stock Options (Right to buy)

    2023-08-028,4506,850 total
    Exercise: $102.51From: 2020-02-19Exp: 2029-02-19Common Stock (8,450 underlying)
  • Exercise/Conversion

    Common Stock

    2023-08-02$100.92/sh+13,884$1,401,17326,700 total
  • Exercise/Conversion

    Stock Options (Right to buy)

    2023-08-0213,8840 total
    Exercise: $100.92From: 2019-06-21Exp: 2028-06-21Common Stock (13,884 underlying)
Footnotes (4)
  • [F1]The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $370.00 to $370.96, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
  • [F2]The price reported in Column 4 is an average price. These shares were purchased in multiple transactions at prices ranging from $371.00 to $371.05, inclusive. The reporting person undertakes to provide to West Pharmaceutical Services, Inc., any security holder of West Pharmaceutical Services, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range in this footnote.
  • [F3]This award vests in four equal annual installments beginning on February 19, 2020.
  • [F4]This award vests over four years starting on the first anniversary date of the award.

Issuer

WEST PHARMACEUTICAL SERVICES INC

CIK 0000105770

Entity typeother

Related Parties

1
  • filerCIK 0001658001

Filing Metadata

Form type
4
Filed
Aug 7, 8:00 PM ET
Accepted
Aug 8, 3:49 PM ET
Size
17.9 KB